GARUX
Price
$11.41
Change
+$0.04 (+0.35%)
Updated
Jun 2 closing price
Net Assets
6.15B
GCRTX
Price
$9.59
Change
+$0.03 (+0.31%)
Updated
Jun 2 closing price
Net Assets
6.15B
Interact to see
Advertisement

GARUX vs GCRTX

Header iconGARUX vs GCRTX Comparison
Open Charts GARUX vs GCRTXBanner chart's image
GARUX vs GCRTX Comparison Chart in %
View a ticker or compare two or three
VS
GARUX vs. GCRTX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GARUX is a StrongBuy and GCRTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GARUX (6.15B) and GCRTX (6.15B) have equal amount of cash in the bank . GARUX pays higher dividends than GCRTX: GARUX (0.46) vs GCRTX (0.00). GARUX was incepted earlier than GCRTX: GARUX (11 years) vs GCRTX (18 years). GCRTX (1.91) is less costly to investors than GARUX (0.79). GARUX (134.00) and GCRTX (134.00) have comparable annual turnover. GCRTX has a lower initial minimum investment than GARUX: GCRTX (1000) vs GARUX (5000000). GARUX annual gain was more profitable for investors over the last year : 12.91 vs. GCRTX (11.29). GARUX return over 5 years is better than : 17.75 vs. GCRTX (9.40).
GARUXGCRTXGARUX / GCRTX
Total Expense Ratio0.731.8539%
Annual Report Gross Expense Ratio0.791.9141%
Fund Existence11 years18 years-
Gain YTD6.3615.987106%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.15B6.15B100%
Annual Yield % from dividends0.460.00-
Returns for 1 year12.9111.29114%
Returns for 3 years29.4824.90118%
Returns for 5 years17.759.40189%
Returns for 10 years41.9623.50179%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCINX13.59N/A
N/A
VALIC Company I International Growth
FSMEX43.98N/A
N/A
Fidelity Select Medical Tech and Devcs
ISFIX20.51N/A
N/A
VY® Columbia Contrarian Core I
FRBRX189.71N/A
N/A
Franklin Biotechnology Discovery R6
JHEQX34.71N/A
N/A
JPMorgan Hedged Equity I